Melanoma/Skin Cancer News

DENVER — Survival of Merkel cell carcinoma can be impacted by primary tumor site, with head and neck tumors showing the highest rates of morbidity, according to a study presented here.

Parker Institute for Cancer Immunotherapy added Dana-Farber Cancer Institute and Gladstone Institutes to its immuno-oncology research partnership network.

DENVER — Individuals with skin of color are more likely to have pigmented basal cell carcinoma and present with keratinocyte carcinoma at a younger age than white non-Hispanic individuals, according to a study presented here.

DENVER — Ropivacaine duration varies by anatomic region, with the anesthesia lasting shorter amounts of time in highly vascular regions, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

CHICAGO — OCT accurately staged skin cancers, allowing for better diagnosis of basal cell carcinoma, prediction of margins and improved planning for Mohs surgery, according to a study presented here.

An experimental test may help predict which patients with cancer may develop disease recurrence after immunotherapy treatment, according to study results published in Clinical Cancer Research.

Anxiety and depression that may follow a cancer diagnosis, especially as a patient approaches the end of life, can be incapacitating and difficult to assuage.

This year’s European Society for Medical Oncology Congress featured potentially practice-changing research in kidney cancer, cutaneous squamous cell carcinoma, lung cancer and melanoma.

It is well known that obesity, physical inactivity and a poor diet increase the risk for various cancer types and contribute to adverse outcomes among adults with certain malignancies.

Adjuvant nivolumab extended RFS compared with placebo among patients with stage IIB/stage IIC melanoma, according to topline data released by the agent’s manufacturer.